Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Asset disposition Inv. presentation Quarterly results Appointed director
|
BLUE RIDGE BANKSHARES, INC. (BRBS)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/07/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
07/31/2023 |
8-K
| Quarterly results |
07/17/2023 |
8-K
| Quarterly results |
07/13/2023 |
8-K
| Other Events Interactive Data |
05/08/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
05/02/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
04/27/2023 |
8-K
| Quarterly results |
04/05/2023 |
SC 13G/A
| Spurzem Richard T reports a 10% stake in Blue Ridge Bankshares, Inc. |
03/10/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
02/23/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
02/14/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/10/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/07/2023 |
SC 13G
| BlackRock Inc. reports a 5.3% stake in BLUE RIDGE BANKSHARES, INC. |
02/02/2023 |
8-K
| Quarterly results
Docs:
|
"Blue Ridge Bankshares, Inc. Announces Fourth Quarter and Full Year 2022 Results CHARLOTTESVILLE, VA, Feb. 2, 2023 -- Blue Ridge Bankshares, Inc. , the holding company of Blue Ridge Bank, National Association and BRB Financial Group, Inc. , announced today financial results for the quarter and full year ended December 31, 2022. For the fourth quarter of 2022, the Company reported net income from continuing operations of $6.3 million, or $0.33 earnings per diluted common share, compared to $2.7 million, or $0.15 earnings per diluted common share, for the third quarter of 2022, and $12.8 million, or $0.68 earnings per diluted common share, for the fourth quarter of 2021. For the year ended December 31, 2022, the Company reported net income from continuing operations of $27.6 million, or $1.47..." |
|
01/10/2023 |
8-K
| Other Events Interactive Data |
12/27/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
12/07/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
11/07/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
11/03/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
11/02/2022 |
8-K
| Quarterly results |
10/27/2022 |
8-K
| Quarterly results |
10/11/2022 |
8-K
| Other Events Interactive Data |
09/01/2022 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
08/05/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
08/02/2022 |
8-K
| Investor presentation |
07/28/2022 |
8-K
| Quarterly results |
07/07/2022 |
8-K
| Quarterly results |
06/30/2022 |
8-K
| Quarterly results |
06/29/2022 |
8-K
| Quarterly results |
06/17/2022 |
FWP
| Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses: |
06/16/2022 |
8-K
| Quarterly results |
05/26/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
05/23/2022 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
05/11/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
|
|
|